Shanghai Center for Plant Stress Biology, CAS Center of Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai 200032, China.
University of Chinese Academy of Sciences (CAS), Beijing, 100049, China.
Int J Mol Sci. 2018 Dec 7;19(12):3925. doi: 10.3390/ijms19123925.
The CRISPR/Cas9 system has been widely used for targeted genome editing in numerous plant species. In , constitutive promoters usually result in a low efficiency of heritable mutation in the T1 generation. In this work, CRISPR/Cas9 gene editing efficiencies using different promoters to drive expression were evaluated. Expression of under the constitutive CaMV 35S promoter resulted in a 2.3% mutation rate in T1 plants and failed to produce homozygous mutations in the T1 and T2 generations. In contrast, expression of under two cell division-specific promoters, and , produced mutation rates of 80.9% to 100% in the T1 generation with nonchimeric mutations in the T1 (4.4⁻10%) and T2 (32.5⁻46.1%) generations. The promoter was used to modify a previously reported multiplex CRISPR/Cas9 system, replacing the original constitutive ubiquitin promoter. The multi-pCDC45-Cas9 system produced higher mutation efficiencies than the multi-pUBQ-Cas9 system in the T1 generation (60.17% vs. 43.71%) as well as higher efficiency of heritable mutations (11.30% vs. 4.31%). Sextuple T2 homozygous mutants were identified from a construct targeting seven individual loci. Our results demonstrate the advantage of using cell division promoters for CRISPR/Cas9 gene editing applications in , especially in multiplex applications.
CRISPR/Cas9 系统已被广泛应用于众多植物物种的靶向基因组编辑。在植物中,组成型启动子通常导致 T1 代可遗传突变的效率较低。在这项工作中,评估了使用不同启动子驱动 表达的 CRISPR/Cas9 基因编辑效率。在组成型 CaMV 35S 启动子下表达 导致 T1 植物的突变率为 2.3%,并且在 T1 和 T2 代中未能产生纯合突变。相比之下,在两个细胞分裂特异性启动子 和 下表达 ,在 T1 代产生 80.9%至 100%的突变率,T1(4.4⁻10%)和 T2(32.5⁻46.1%)代中非嵌合突变。使用 启动子修饰了先前报道的多路复用 CRISPR/Cas9 系统,替代了原始组成型泛素启动子。多-pCDC45-Cas9 系统在 T1 代中的突变效率高于多-pUBQ-Cas9 系统(60.17%比 43.71%),并且具有更高的可遗传突变效率(11.30%比 4.31%)。从针对七个独立靶位点的构建体中鉴定出六个 T2 代纯合突变体。我们的结果表明,在 中,特别是在多路复用应用中,使用细胞分裂启动子进行 CRISPR/Cas9 基因编辑应用具有优势。